Stephen Mahoney - Insider Trading & Ownership

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Summary
The estimated net worth of Stephen Mahoney is at least $706K dollars as of September 30, 2024. Stephen Mahoney is the President and CEO, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $499K. Stephen Mahoney is the Title: Chief Financial and Operating Officer of Magenta Therapeutics, Inc. and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $207K.
All Insider Reports
All Insider Reports

Ownership of Stephen Mahoney

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VRDN Viridian Therapeutics, Inc.\DE President and CEO, Director $499K +$499K Sep 27, 2024
DNTH Dianthus Therapeutics, Inc. /DE/ Title: Chief Financial and Operating Officer $207K Nov 30, 2022

Insider Transactions Reported by Stephen Mahoney:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.